Vaccine Development: Steps to Approval of an Investigational Vaccine

References

1. 1.↵
   1. Centers for Disease Control and Prevention (CDC)

   . Ten great public health achievements—United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48(12):241-243.

   OpenUrlPubMed
2. 2.↵
   1. Kanesa-thasan N,
   2. Shaw A,
   3. Stoddard JJ,
   4. Vernon TM.

   Ensuring the optimal safety of licensed vaccines: A perspective of the vaccine research, development, and manufacturing companies. Pediatrics. 2011;127(suppl 1):S16-S22. doi: 10.1542/peds.2010-1722D

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. US Food and Drug Administration

   . Classification of Products as Drugs and Devices and Additional Product Classification Issues. FDA website. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/classification-products-drugs-and-devices-and-additional-product-classification-issues#drug. Published September 2017. Accessed October 22, 2020.
4. 4.↵
   1. US Food and Drug Administration

   . What Are “Biologics” Questions and Answers. https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/what-are-biologics-questions-and-answers. Published February 6, 2018. Accessed October 22, 2020.
5. 5.↵
   Public Health: Immunization required, § 130A-152 (1957, 2007).
6. 6.↵
   1. Marshall V,
   2. Baylor NW.

   Food and Drug Administration regulation and evaluation of vaccines. Pediatrics. 2011;127(suppl 1):S23-S30. doi: 10.1542/peds.2010-1722E

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Preiss S,
   2. Garçon N,
   3. Cunningham AL,
   4. Strugnell R,
   5. Friedland LR.

   Vaccine provision: Delivering sustained & widespread use. Vaccine. 2016;34(52):6665-6671. doi: 10.1016/j.vaccine.2016.10.079

   OpenUrlCrossRef
8. 8.↵
   1. Plotkin SA.

   Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010;17(7):1055-1065. doi: 10.1128/CVI.00131-10

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. US Food and Drug Administration

   . Biologics License Applications (BLA) Process (CBER). https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/biologics-license-applications-bla-process-cber. Updated November 20, 2020. Accessed October 22, 2020.
10. 10.↵
    1. Pickering LK,
    2. Meissner HC,
    3. Orenstein WA,
    4. Cohn AC.

    Principles of vaccine licensure, approval, and recommendations for use. Mayo Clin Proc. 2020;95(3):600-608. doi: 10.1016/j.mayocp.2019.11.002

    OpenUrlCrossRef
11. 11.↵
    1. US Food and Drug Administration

    . Postmarketing Requirements and Commitments: Introduction. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/postmarket-requirements-and-commitments. Published January 12, 2016. Accessed October 22, 2020.
12. 12.↵
    1. US Department of Health & Human Services: Vaccines

    . Vaccine Safety. Vaccines.gov website. https://www.vaccines.gov/basics/safety. Updated February 2020. Accessed October 22, 2020.